阿替普酶静脉溶栓治疗急性心肌梗死临床观察

摘要

Objective To explore the alteplase intravenous thrombolytic therapy in acute myocardial infarction clinical Results . Methods 68 casesof acute myocardial infarction in our hospital from 2014 January to 2015 March were divided into a control group according to the draw (was treated with 50mg intravenous alteplase thrombolysis) and study group (was treated with administered 100 mg acceleration alteplase intravenous thrombolytic therapy), with 34 cases in each group,, the treatment effect were compared in two groups. Results The two groups were invalid, bleeding, death and other indicators, there was not statistical signiifcance (P>0.05), the study group was significantly higher recanalization rate, there was statistical significance (P < 0.05). Conclusion Acute myocardial infarction using alteplase intravenous thrombolytic therapy, accelerated delivery Methods of treatment effect is ideal.%目的 观察阿替普酶静脉溶栓治疗急性心肌梗死临床效果.方法 选取2014年1月~2015年3月我院收治的68例急性心肌梗死患者按照抽签法分为对照组(予以50mg阿替普酶静脉溶栓治疗)和研究组(予以100mg加速给药阿替普酶静脉溶栓治疗),各34例,比较两组治疗效果.结果 两组患者无效、出血、死亡等指标进行比较,差异无统计学意义(P>0.05);研究组再通率高于对照组,差异具有统计学意义(P<0.05).结论 急性心肌梗死采用阿替普酶静脉溶栓治疗,加速给药方法治疗效果比较理想.